World's Best Scientists 2026 revealed!
Terra L. Lasho

Terra L. Lasho

D-Index & Metrics

Medicine

D-Index
90
Citations
29174
World Ranking
12222
National Ranking
6262

Overview

Terra L. Lasho is a researcher affiliated with the Mayo Clinic in the United States, with a substantial body of work spanning medicine, biochemistry, genetics, and molecular biology. Their research primarily focuses on hematology, genetics, and cancer-related fields, including acute myeloid leukemia and myeloproliferative neoplasms.

Lasho's publications reflect active contributions to several key topics, including:

  • Acute Myeloid Leukemia Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Cancer Genomics and Diagnostics
  • Chronic Myeloid Leukemia Treatments
  • Protein Degradation and Inhibitors
  • Otitis Media and Relapsing Polychondritis

Their research has appeared frequently in high-impact journals, with notable publication venues comprising:

  • Blood
  • American Journal of Hematology
  • Leukemia
  • Leukemia Research
  • Haematologica

Recent papers authored or coauthored by Lasho include:

  • "Mutation-enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera," 2020, British Journal of Haematology
  • "Spectrum of clonal hematopoiesis in VEXAS syndrome," 2023, Blood
  • "RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis," 2021, Nature Communications
  • "Single-cell genomics reveals the genetic and molecular bases for escape from mutational epistasis in myeloid neoplasms," 2020, Blood
  • "VEXAS syndrome: Clinical, hematologic features and a practical approach to diagnosis and management," 2023, American Journal of Hematology

Lasho has collaborated regularly with several coauthors, indicating an active position in a network of hematology researchers. Frequent collaborators include:

  • Mrinal M. Patnaik
  • Christy Finke
  • Abhishek A. Mangaonkar
  • Naseema Gangat
  • Ayalew Tefferi

Their primary fields of study encompass medicine with 237 publications and biochemistry, genetics, and molecular biology with 77 publications. Within these fields, Lasho specializes in hematology, genetics, molecular biology, cancer research, and pathology and forensic medicine, with a publication distribution indicating a focus on hematology (111 publications) and genetics (77 publications).

Best Publications

  • MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients

    Animesh D. Pardanani;Ross L. Levine;Terra Lasho;Yana Pikman

  • Long-term survival and blast transformation in molecularly-annotated essential thrombocythemia, polycythemia vera and myelofibrosis

    Ayalew Tefferi;Paola Guglielmelli;Dirk R. Larson;Christy Finke

  • Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors

    Ken Hong Lim;Ayalew Tefferi;Terra L. Lasho;Christy Finke

  • CALR vs JAK2 vs MPL -mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons

    A Tefferi;T L Lasho;C M Finke;R A Knudson

  • The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes.

    David P. Steensma;David P. Steensma;Gordon W. Dewald;Gordon W. Dewald;Terra L. Lasho;Terra L. Lasho;Heather L. Powell;Heather L. Powell

  • Circulating Interleukin (IL)-8, IL-2R, IL-12, and IL-15 Levels Are Independently Prognostic in Primary Myelofibrosis: A Comprehensive Cytokine Profiling Study

    Ayalew Tefferi;Rakhee Vaidya;Rakhee Vaidya;Domenica Caramazza;Domenica Caramazza;Christy Finke;Christy Finke

  • TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis

    A. Tefferi;A. Pardanani;K. H. Lim;K. H. Lim;O. Abdel-Wahab

  • MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis.

    Paola Guglielmelli;Terra L. Lasho;Giada Rotunno;Mythri Mudireddy

  • JAK2V617F mutation in essential thrombocythaemia: clinical associations and long‐term prognostic relevance

    Alexandra P. Wolanskyj;Terra L. Lasho;Susan M. Schwager;Rebecca F. McClure

  • FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia.

    Animesh Pardanani;Stephanie R. Brockman;Sarah F. Paternoster;Heather C. Flynn

  • TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L/K mutations

    A Pardanani;J Hood;T Lasho;R L Levine

  • IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis

    A Tefferi;T L Lasho;O Abdel-Wahab;P Guglielmelli

  • Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia vera.

    A Pardanani;T L Lasho;C Finke;C A Hanson

  • The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients.

    Paola Guglielmelli;Terra L. Lasho;Giada Rotunno;Joannah Score

  • MIPSS70+ Version 2.0: Mutation and Karyotype-Enhanced International Prognostic Scoring System for Primary Myelofibrosis

    Ayalew Tefferi;Paola Guglielmelli;Terra L. Lasho;Naseema Gangat

  • Targeted deep sequencing in polycythemia vera and essential thrombocythemia

    Ayalew Tefferi;Terra L. Lasho;Paola Guglielmelli;Christy M. Finke

  • Low JAK2V617F allele burden in primary myelofibrosis, compared to either a higher allele burden or unmutated status, is associated with inferior overall and leukemia-free survival

    A Tefferi;T L Lasho;J Huang;C Finke

  • CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients

    A Tefferi;P Guglielmelli;T L Lasho;G Rotunno

  • Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates

    Tefferi A;Levine Rl;Lim Kh;Lim Kh;Abdel-Wahab O

  • A Pilot Study of the Telomerase Inhibitor Imetelstat for Myelofibrosis.

    Ayalew Tefferi;Terra L. Lasho;Kebede H. Begna;Mrinal M. Patnaik

Frequent Co-Authors

Ayalew Tefferi
Ayalew Tefferi Mayo Clinic
Curtis A. Hanson
Curtis A. Hanson Mayo Clinic
Ruben A. Mesa
Ruben A. Mesa The University of Texas Health Science Center at San Antonio
Alessandro M. Vannucchi
Alessandro M. Vannucchi University of Florence
Eric Solary
Eric Solary Institut Gustave Roussy
Mark R. Litzow
Mark R. Litzow Mayo Clinic
Paola Guglielmelli
Paola Guglielmelli University of Florence

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative pathways in healthcare is a smart move for students considering a career in medicine. Many accredited programs in nursing and advanced practice now offer online study options, making it more affordable and flexible to advance your career.

For those aiming to become nurse practitioners, enrolling in one of the cheapest fnp programs online can be a cost-effective way to gain expertise and boost job prospects. Students interested in leadership or specialized nursing roles should also look into the cheapest online msn programs, which provide the skills needed to move into management positions.

If you’re considering a future in academic research or higher-level practice, pursuing an online phd nursing can open doors to university faculty positions or specialized research roles. Meanwhile, practicing nurses who want to enhance their credentials and earning potential should consider the rn to bsn online cost options—these bridge programs offer a flexible, affordable way to advance quickly.

These online programs offer various entry points and career outcomes, giving aspiring healthcare professionals plenty of choices to fit their interests and schedules.

Best Scientists Citing Terra L. Lasho

Trending Scientists

Recently Published Articles